Silver dressing may soothe radiation burns in breast cancer patients

NCT ID NCT06831084

Completed Symptom relief Sponsor: Parul Barry Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a silver-plated wound dressing (Silverlon) in 17 breast cancer patients receiving radiation therapy. The goal was to see if the dressing could reduce the severity of acute radiation dermatitis, a common skin reaction that causes redness, peeling, and pain. Patients wore the dressing during treatment and for two weeks after, and their skin was checked weekly and one month later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Silver-plated dressing (Silverlon)
What this could lead to: If it works, this could give breast cancer patients a simple way to reduce painful skin rashes during radiation therapy.
What could go wrong: This was a very small, early-phase trial with only 17 people and no comparison group, so results may not apply to everyone. The dressing may not prevent severe skin reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma in situ radiodermatitis prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RADIATION DERMATITIS ACUTE

Contacts and locations

Locations

UPMC Magee-Womens Hospital

Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.